Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes
NCT ID: NCT02761018
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2017-08-08
2018-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-assisted Diabetes Self-management Interventions
NCT00006163
Wearable Devices on Health Promotion in Diabetes
NCT07144774
Program ACTIVE: Phase 2
NCT04369001
Pilot Project of Health Promotion for People With Diabetes
NCT00970294
Mobile Health to Enhance Exercise in Type 2 Diabetes
NCT04653532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Screening Visit:
* Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
* Record: Date of birth, phone number, age, gender, race, ethnicity, social security number, current email address, height (in inches), weight (in pounds), blood pressure, medications list including any over-the-counter and prescription weight loss medication (name, strength, dose) or supplements.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Visit 1 (Day 1 within 1 week of Screening Visit):
* Record: Weight (in pounds), blood pressure, and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Intake Questionnaire.
* Subjects will be assigned their Fitness Tracker username and their username and password will be recorded by the Research Coordinator.
* Subjects will be given User Instructions based off of their randomization group.
* Subjects will be instructed to follow all research procedures and that failure to do so may result in the removal from the study and the return of the Fitness Tracker.
* Subjects will be randomized by the research coordinator using a random-number generator into one of two groups (research-driven):
* Group 1: will use a fitness tracker but will not be able to see other participant's data.
* Group 2: will use a fitness tracker and will be able to see other member's daily and weekly results.
* Both groups will receive the scripted feedback at set time intervals by the Research Coordinators.
* Subjects will be provided a fitness tracker and instructed on how to use it.
* If subject is a DoD beneficiary, and finishes all study-related procedures at month 6, they will keep the fitness tracker. If a subject does not complete all study-related procedures, they will be asked to return the fitness tracker so the investigators can erase their data and re-issue to another study subject.
* If subject is active duty or a DoD employee, regardless of their study completion, they will be asked to complete Temporary Issue Receipt and bring back the fitness tracker at the end of the study.
Visit 2 (Month 3/90 days post Visit 1):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Final Visit 3 (Month 6/90 days post Visit 2):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey and be asked some additional questions.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fitness Tracker
will use a fitness tracker but will not be able to see other participant's data
Fitness Tracker
will use a fitness tracker and will be able to see other member's daily and weekly results
Fitness Tracker with Group Participation
will use a fitness tracker and will be able to see other member's daily and weekly results
Behavioral: Fitness Tracker
will use a fitness tracker but will not be able to see other participant's data
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral: Fitness Tracker
will use a fitness tracker but will not be able to see other participant's data
Fitness Tracker
will use a fitness tracker and will be able to see other member's daily and weekly results
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to set up fitness tracking software on personal computer or cell phone
* Ability to learn and use personal activity monitor
Exclusion:
* Male and female DoD beneficiaries, under the age of 18 years
* Unwilling to share personal fitness results anonymously
* Inability to do 4 metabolic equivalents of exercise (walk 100feet, walk up flight of stairs etc).
* Inability to walk without the use of assistive devices (cane is OK)
* Medical problem which would make walking unsafe (recent surgery, uncontrolled heart condition, fall risk etc).
* No special populations (e.g., pregnant women, children, prisoners, detainees) will be recruited.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike O'Callaghan Military Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Carlsen, MD
Role: PRINCIPAL_INVESTIGATOR
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mike O'Callaghan Federal Medical Center
Nellis Air Force Base, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20160062H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.